# Genmab A/S: Form 6-K, filed Sep 24, 2026

- Company: [Genmab A/S](/companies/gmab.md) (CIK 1434265)
- Form: 6-K
- Filed: 2026-09-24
- Accepted by EDGAR: Sep 24, 2026, 14:45 ET
- Period: 2026-09-24
- Accession: 0001434265-26-000125
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000125/gmab_20260924x6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000125/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434265/000143426526000125/gmab_20260924x6k.htm

Filed Sep 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001434265-26-000125. Last ingested by Listed: Nov 13, 2026, 10:58 ET. No prices; not investment advice.
